Source disclosure: February 20, 2026
Astena Holdings Co.,Ltd. [8095.T]
TOKYO, Feb 20 (Pulse News Wire) -- Astena Holdings Co., Ltd. (8095.T), represented by President and CEO Satoshi Seshiguchi, has announced that it will receive dividend payments totaling ¥464 million from its subsidiary, Iwajyo Pharmaceutical Co., Ltd. The dividend resolution was made on January 22, 2026, during a board meeting held by the subsidiary company. According to the Financial Instruments and Exchange Act Article 24, Paragraph 5, Item 4 and Cabinet Order No. 19, Item 2, Subitem 12 regarding the Disclosure of Corporate Information, this information is being disclosed as it meets the criteria for a special report submission requirement.
The dividend amount of ¥464 million will be received by Astena Holdings on February 25, 2026. This dividend income will be reflected in the standalone operating revenue for the fiscal year ending November 2026. However, since the dividends come from a consolidated subsidiary, they will not impact the consolidated earnings for the same period.
AI-translated content. 🟡 Confidence: Standard See terms • Original filing